Finoriq research workspace
Cencora, Inc. (COR) Institutional Holdings & 13F Ownership
Cencora, Inc. sources and distributes pharmaceutical products in the United States. Review COR institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
- Company
- Cencora, Inc. (COR)
- Ticker
- COR
- Market Cap
- $59.3B
- Latest Price
- $304.91
- Industry
- Other Pharmaceuticals
Cencora, Inc. (COR) Top Institutional Holders
Top current 13F holders indexed for Cencora, Inc. (COR). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Joel GreenblattCIK 0001510387 | $16.1M | 0.05% | Filing2026-05-15 |
| 2 | Ray DalioCIK 0001350694 | $4.5M | 0.02% | Filing2026-05-15 |
| 3 | Ken FisherCIK 0000850529 | $922,634 | 0.0% | Filing2026-05-05 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.